Modelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies

AIMS Cell and Tissue Engineering

Elodie J Siney¹ 

[1] 1 WISH laboratories, University Hospital Southampton, Southampton, UK2 Centre for Biological Sciences, University of Southampton, Southampton, UK3 Clinical Neurosciences, Faculty of Medicine and Centre for Human Development, Stem Cells and regenerative Medicine, University of Southampton, Southampton, UK

关键词: induced pluripotent stem cells;    neural stem cells;    3D;    culture model;    microenvironment;    matrix;    neural differentiation;    neurodegenerative diseases;    Alzheimer;   

DOI  :  10.3934/celltissue.2018.1.1

学科分类：医学（综合）

来源: AIMS Press

【 摘 要 】

The discovery of induced pluripotent stem cells (iPSC) 12 years ago has fostered the development of innovative patient-derived in vitro models for better understanding of disease mechanisms. This is particularly relevant to neurodegenerative diseases, where availability of live human brain tissue for research is limited and post-mortem interval changes influence readouts from autopsy-derived human tissue. Hundreds of iPSC lines have now been prepared and banked, thanks to several large scale initiatives and cell banks. Patient- or engineered iPSC-derived neural models are now being used to recapitulate cellular and molecular aspects of a variety of neurodegenerative diseases, including early and pre-clinical disease stages. The broad relevance of these models derives from the availability of a variety of differentiation protocols to generate disease-specific cell types and the manipulation to either introduce or correct disease-relevant genetic modifications. Moreover, the use of chemical and physical three-dimensional (3D) matrices improves control over the extracellular environment and cellular organization of the models. These iPSC-derived neural models can be utilised to identify target proteins and, importantly, provide high-throughput screening for drug discovery. Choosing Alzheimer’s disease (AD) as an example, this review describes 3D iPSC-derived neural models and their advantages and limitations. There is now a requirement to fully characterise and validate these 3D iPSC-derived neural models as a viable research tool that is capable of complementing animal models of neurodegeneration and live human brain tissue. With further optimization of differentiation, maturation and aging protocols, as well as the 3D cellular organisation and extracellular matrix to recapitulate more closely, the molecularextracellular-environment of the human brain, 3D iPSC-derived models have the potential to deliver new knowledge, enable discovery of novel disease mechanisms and identify new therapeutic targets for neurodegenerative diseases.

【 授权许可】

CC BY